CA: A Cancer Journal for Clinicians

As the flagship journal of the American Cancer Society, CA publishes the latest cancer statistics, ACS guidelines, and reviews on the current state of cancer.

[CA: A Cancer Journal for Clinicians @CACancerJournal]

🌍 New Global Cancer Stats from @AmericanCancer @IARCWHO show 20.6 million people were diagnosed with cancer and 9.8 million died from cancer worldwide in 2024. The global cancer burden is projected to rise 53% to 31.5M by 2050.

https://t.co/lLvzxxrxVq

@FreddieBray_ @OncoAlert

[Jame Abraham, MD, FACP @jamecancerdoc]

Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries - Sung - 2026 - CA: A Cancer Journal for Clinicians - Wiley Online Library https://t.co/qWLgQyaBWN @JournalCancer @OncoAlert

[CA: A Cancer Journal for Clinicians @CACancerJournal]

An accompanying editorial to the @AmericanCancer Global Cancer Statistics 2024 report explores why accurate data are the foundation of equitable cancer control and what the latest ovarian cancer statistics reveal.

https://t.co/QEOxonqIng

@OncoAlert @StephensonCC @BuffettCancer

[CA: A Cancer Journal for Clinicians @CACancerJournal]

CA: A Cancer Journal for Clinicians is accepting proposals for high-impact Phase III trials that may inform standards of care. Accepted submissions may qualify for rapid review to align with conference proceedings. Learn more: https://t.co/U375PWNzLL @OncoAlert

[CA: A Cancer Journal for Clinicians @CACancerJournal]

Revisit this review by @yayaxiawu et al on systemic amyloid light‐chain amyloidosis beyond ANDROMEDA trial summarizing diagnostic challenges & therapeutic updates. Emphasis on practical diagnostic algorithms & evolving response assessment.

https://t.co/w0tH1nXwPL

@OncoAlert

[Yakup Ergün @dr_yakupergun]

🚨New GLOBOCAN 2024 data show that the global cancer burden is not only increasing, but also widening inequalities. Incidence is higher in developed countries, whereas mortality is disproportionately greater in LMICs. By 2050, new cancer cases may reach 34.4 million!

New drugs alone will not be enough; prevention, early detection, and equitable access are essential🌍🌎🌏

https://t.co/aqbxpoQOet

[Yüksel Ürün @DrYukselUrun]

Cancer will rise fastest where health systems are most fragile!
20.6M new cancer cases. 9.8M deaths.
By 2050, 34.4M cases are expected.
The future burden will fall hardest on lower-HDI countries.
The solution: prevention, early diagnosis, and access.
#Cancer #equity #access
@OncoAlert @OpenMedicineHQ @CACancerJournal @WHO @ASCO @myESMO @uicc @AfriCF

[CA: A Cancer Journal for Clinicians @CACancerJournal]

What does cancer survivorship research look like today? This virtual collection from the @AmericanCancer Journals features the latest statistics and research articles on patient needs, long-term outcomes, and more.

🔗 https://t.co/Xtet4MyKNG

@OncoAlert @JournalCancer

[CA: A Cancer Journal for Clinicians @CACancerJournal]

Prostate cancer is the 2nd most diagnosed cancer among men and 4th leading cause of cancer death, with 1.5M new cases and 420,000 deaths. Prostate cancer mortality is disproportionately higher in the Caribbean and Sub-Saharan Africa.

https://t.co/lLvzxxrxVq

@OncoAlert @IARCWHO

[CA: A Cancer Journal for Clinicians @CACancerJournal]

Lung cancer is the leading cause of cancer worldwide, with nearly 2.6M cases and 1.9M deaths each year. Lung cancer is also the leading cause of cancer death in men in 89 countries. #LCSM

Find more global cancer statistics at:
https://t.co/lLvzxxrxVq

@OncoAlert @IARCWHO

[ACSNews @ACSNews]

New research out today in @CACancerJournal led by @AmericanCancer Dr. Hyuna Sung reports latest Global Cancer Statistics. #Cancer cases approach 21 million worldwide, with burden projected to surge 67% by 2050. Read more here👉https://t.co/7bwRc2X3Ls

[CA: A Cancer Journal for Clinicians @CACancerJournal]

New #OpenAccess review on serious mental illness and cancer: Recommendations for improving cancer care through collaborative care model adoption, psychosocial and psychiatric integration, and clinician bias training. https://t.co/v6ZIW32xRp

@OncoAlert @crisbergerot

[CA: A Cancer Journal for Clinicians @CACancerJournal]

Regular physical activity & a healthy diet are 2 of the most important modifiable factors for long-term health for #CancerSurvivors. 🥦🏊‍♂️

Share this infographic and access the latest recommendations from @AmericanCancer: https://t.co/kR85uh1sqa

@OncoAlert

[CA: A Cancer Journal for Clinicians @CACancerJournal]

Our Patient Pages provide highly relevant, evidence-based medical content in a structured and concise format designed to address typical patient questions concerning diseases and their related symptoms, prevention, and treatment.

https://t.co/PFhM3S4Wmv

@OncoAlert

[CA: A Cancer Journal for Clinicians @CACancerJournal]

.@AmericanCancer estimates 93% of US skin melanoma is attributable to UV radiation.

Stay sun safe:
☀️ Seek shade
🧢 Wear protective clothing
🧴 Regularly apply broad-spectrum SPF 30+ sunscreen

Learn more about modifiable cancer risk factors:
https://t.co/RRGBFGptud

@OncoAlert

[CA: A Cancer Journal for Clinicians @CACancerJournal]

Revisit for #TumorBoardTuesday! Medullary thyroid carcinoma and RET molecular testing: A virtual tumor board on clinical decision-making

https://t.co/6EhUFcc15e

@OncoAlert

[CA: A Cancer Journal for Clinicians @CACancerJournal]

ENKTCL was once one of the most fatal forms of non-Hodgkin lymphoma, but now ~80% of newly diagnosed patients can achieve long-term survival, largely driven by targeted therapeutic approaches.

Learn more from this new review by Zhao, et al:
https://t.co/gRA7ehuaCo

@OncoAlert

[CA: A Cancer Journal for Clinicians @CACancerJournal]

Eating nutritious foods can help cancer survivors manage their energy levels, feel better, and stay stronger. 🥗🍉🍇

Our infographic shares general tips for eating well during treatment. Access the full @AmericanCancer recommendations: https://t.co/kR85uh1sqa

@OncoAlert

[CA: A Cancer Journal for Clinicians @CACancerJournal]

AL amyloidosis is no longer a therapeutic dead end. Daratumumab transformed frontline care, and now bispecific antibodies and CAR-T are pushing toward deeper, MRD-negative remissions and durable organ recovery.

Earlier diagnosis is key: https://t.co/w0tH1nXwPL

@OncoAlert

[CA: A Cancer Journal for Clinicians @CACancerJournal]

New Perspectives article finds ovarian cancer survivors who are BRCA carriers have a relatively low risk of breast cancer. Risk-reducing mastectomy is not necessary and MRI and/or mammography surveillance is a realistic alternative.

https://t.co/8Gn9KNpL8v

@OncoAlert #gyncsm